| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.069 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | VER-155008 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.03 | 0.4 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | 0.066 | 0.4 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.4 |